Peltenburg LT - Search Results

1

Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.

Peltenburg LT, Schrier PI. Peltenburg LT, et al. Immunogenetics. 1994;40(1):54-61. doi: 10.1007/BF00163964. Immunogenetics. 1994. PMID: 8206526

2

c-myc-induced natural killer cell sensitivity of human melanoma cells is reversed by HLA-B27 transfection.

Peltenburg LT, Steegenga WT, Krüse KM, Schrier PI. Peltenburg LT, et al. Eur J Immunol. 1992 Oct;22(10):2737-40. doi: 10.1002/eji.1830221040. Eur J Immunol. 1992. PMID: 1396976

3

Sensitivity of melanoma cell lines to natural killer cells: a role for oncogene-modulated HLA class I expression?

Schrier PI, Versteeg R, Peltenburg LT, Plomp AC, van 't Veer LJ, Krüse-Wolters KM. Schrier PI, et al. Among authors: peltenburg lt. Semin Cancer Biol. 1991 Feb;2(1):73-83. Semin Cancer Biol. 1991. PMID: 1912519

4

High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells.

Versteeg R, Peltenburg LT, Plomp AC, Schrier PI. Versteeg R, et al. Among authors: peltenburg lt. J Immunol. 1989 Dec 15;143(12):4331-7. J Immunol. 1989. PMID: 2512356

5

Relationship between myc oncogene activation and MHC class I expression.

Schrier PI, Peltenburg LT. Schrier PI, et al. Among authors: peltenburg lt. Adv Cancer Res. 1993;60:181-246. doi: 10.1016/s0065-230x(08)60826-x. Adv Cancer Res. 1993. PMID: 8417500 Review. No abstract available.

6

Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A.

Peltenburg LT, Dee R, Schrier PI. Peltenburg LT, et al. Nucleic Acids Res. 1993 Mar 11;21(5):1179-85. doi: 10.1093/nar/21.5.1179. Nucleic Acids Res. 1993. PMID: 8464702 Free PMC article.

7

C-myc represses transiently transfected HLA class I promoter sequences not locus-specifically.

Griffioen M, Peltenburg LT, van Oorschot DA, Schrier PI. Griffioen M, et al. Among authors: peltenburg lt. Immunobiology. 1995 Jul;193(2-4):238-47. doi: 10.1016/S0171-2985(11)80549-8. Immunobiology. 1995. PMID: 8530149

8

Repression of the minimal HLA-B promoter by c-myc and p53 occurs through independent mechanisms.

Griffioen M, Steegenga WT, Ouwerkerk IJ, Peltenburg LT, Jochemsen AG, Schrier PI. Griffioen M, et al. Among authors: peltenburg lt. Mol Immunol. 1998 Sep;35(13):829-35. doi: 10.1016/s0161-5890(98)00074-1. Mol Immunol. 1998. PMID: 9839551

9

p53 expression in human rectal tissue after radiotherapy: upregulation in normal mucosa versus functional loss in rectal carcinomas.

Marijnen CA, Kapiteijn E, Nagtegaal ID, Mulder-Stapel AA, van de Velde CJ, Schrier PI, Peltenburg LT, van Krieken JH. Marijnen CA, et al. Among authors: peltenburg lt. Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):720-8. doi: 10.1016/s0360-3016(01)02674-8. Int J Radiat Oncol Biol Phys. 2002. PMID: 11849795 Clinical Trial.

10

c-Myc is able to sensitize human melanoma cells to diverse apoptotic triggers.

Peltenburg LT, de Bruin EC, Meersma D, Wilting S, Jürgensmeier JM, Schrier PI. Peltenburg LT, et al. Melanoma Res. 2004 Feb;14(1):3-12. doi: 10.1097/00008390-200402000-00002. Melanoma Res. 2004. PMID: 15091188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters